Lexicon Pharmaceuticals (LXRX)

• Market cap: $691M
• 1 day: 1.24%
• 5 days: -2.98%
• 1 month: -0.61%
• 3 months: 30.4%
• 6 months: 19.85%
• Year to date: 42.98%
• 1 year: 124.98%
• 5 years: -66.32%
• 10 years: -88.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Employees: 81